Janssen pharmaceutica
Janssen Pharmaceutica compagnie pharmaceutique belge filiale de Johnson & Johnson
VIAF ID: 125497068 ( Corporate )
Permalink: http://viaf.org/viaf/125497068
Preferred Forms
-
-
-
- 110 2 _ ‡a Janssen Pharmaceutica
- 110 2 _ ‡a Janssen Pharmaceutica ‡c compagnie pharmaceutique belge filiale de Johnson & Johnson
- 110 2 _ ‡a Janssen pharmaceutica
- 210 | | ‡a Janssen pharmaceutica
- 110 2 _ ‡a Janssen pharmaceutica
4xx's: Alternate Name Forms (17)
Works
Title | Sources |
---|---|
Alergie se nevyhýbá ani dětem novinka - Astemizole Hismanal suspenze : pro děti předškolního věku | |
Astemizole : a new, non-sedative, long-acting H₁-antagonist : proceedings of a symposium held in Beerse, Belgium, October, 1983. | |
The epidemiology and treatment of oral and esophageal candidiasis | |
Even more potent | |
Janssen medisch-wetenschappelijk nieuws. | |
Janssen Pharmaceutica, Cilag 1995 registrované a distribuované léky v ČR ... : [celoroční nástěnný kalendář] | |
The Janssen reporter. | |
L'épidémiologie et le traitement de la candidose orale et oesophagienne | |
Nausea and vomiting : mechanisms and treatment | |
The Pharmacological basis of migraine therapy | |
Risperdal : risperidone, clinical monograph. | |
Statistická klasifikace nemocí | |
Tajemství rýmy | |
Toxicology reference data, Wistar rat : body and organ weights, biochemical determinations, hematology, and urinalysis, compiled at Janssen Pharmaceutica | |
Troubles de la motilité des voies digestives supérieures : principaux extraits de symposium | |
Upper gastrointestinal motility disorders : symposium highlights, Toronto, 1985 |